Essilor International (ESLOY) Upgraded at Zacks Investment Research

Essilor International (OTCMKTS:ESLOY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Friday.

According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “

Separately, Royal Bank Of Canada began coverage on Essilor International in a research report on Thursday, September 21st. They set an “underperform” rating on the stock.

Shares of Essilor International (OTCMKTS:ESLOY) traded up $0.01 during trading hours on Friday, hitting $64.31. The stock had a trading volume of 18,243 shares, compared to its average volume of 32,256. Essilor International has a 52-week low of $51.71 and a 52-week high of $68.43. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.76 and a current ratio of 1.09.

TRADEMARK VIOLATION WARNING: “Essilor International (ESLOY) Upgraded at Zacks Investment Research” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at

Essilor International Company Profile

Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is a France-based ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals.

Get a free copy of the Zacks research report on Essilor International (ESLOY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with's FREE daily email newsletter.

Leave a Reply